Recurrent infection progressively disables host protection against intestinal inflammation

Science

Volumn 358, Issue 6370, 2017, Pages

  Yang, Won Ho ^a   Heithoff, Douglas M ^a   Aziz, Peter V ^a   Sperandio, Markus ^b   Nizet, Victor ^c   Mahan, Michael J ^a   Marth, Jamey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; PROTEIN ST3GAL6; SIALIDASE; SIALYLTRANSFERASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ZANAMIVIR; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; TLR4 PROTEIN, MOUSE;

ANATOMY; BACTERIAL DISEASE; CHEMICAL REACTION; DISEASE INCIDENCE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENZYME; ENZYME ACTIVITY; FOOD POISONING; INFECTIOUS DISEASE; INHIBITOR; MOLECULAR ANALYSIS; PATHOGEN; PATHOLOGY; PHOSPHATASE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ENTERITIS; ENZYME ACTIVITY; HOST PATHOGEN INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SIALYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COLON; COMPLICATION; DEFICIENCY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; METABOLISM; MICROBIOLOGY; PATHOLOGY; RECURRENT DISEASE; SALMONELLA FOOD POISONING;

MURINAE; NEGIBACTERIA; SALMONELLA ENTERICA;

ALKALINE PHOSPHATASE; ANIMALS; COLON; ENZYME INHIBITORS; INFLAMMATORY BOWEL DISEASES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NEURAMINIDASE; RECURRENCE; SALMONELLA FOOD POISONING; SALMONELLA TYPHIMURIUM; SIALYLTRANSFERASES; TOLL-LIKE RECEPTOR 4; ZANAMIVIR;

EID: 85040199779     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aao5610     Document Type: Article

References (71)

1. N. Figueroa-Bossi, S. Uzzau, D. Maloriol, L. Bossi, Variable assortment of prophages provides a transferable repertoire of pathogenic determinants in Salmonella. Mol. Microbiol. 39, 260–271 (2001). doi: 10.1046/j.1365-2958.2001.02234.x; pmid: 11136448
2. E. Monti et al., Sialidases in vertebrates: A family of enzymes tailored for several cell functions. Adv. Carbohydr. Chem. Biochem. 64, 403–479 (2010). doi: 10.1016/S0065-2318(10) 64007-3; pmid: 20837202
3. W. H. Yang et al., An intrinsic mechanism of secreted protein aging and turnover. Proc. Natl. Acad. Sci. U.S.A. 112, 13657–13662 (2015). doi: 10.1073/pnas.1515464112; pmid: 26489654
4. A. Poltorak et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085–2088 (1998). doi: 10.1126/science.282.5396.2085; pmid: 9851930
5. B. Beutler, Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr. Opin. Microbiol. 3, 23–28 (2000). doi: 10.1016/S1369-5274(99)00046-6; pmid: 10679425
6. M. T. Abreu, Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10, 131–144 (2010). doi: 10.1038/ nri2707; pmid: 20098461
7. H. Huhta et al., The expression of Toll-like receptors in normal human and murine gastrointestinal organs and the effect of microbiome and cancer. J. Histochem. Cytochem. 64, 470–482 (2016). doi: 10.1369/0022155416656154; pmid: 27370795
8. R. Dheer et al., Intestinal epithelial Toll-like receptor 4 signaling affects epithelial function and colonic microbiota and promotes a risk for transmissible colitis. Infect. Immun. 84, 798–810 (2016). doi: 10.1128/IAI.01374-15; pmid: 26755160
9. C. L. Leaphart et al., A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J. Immunol. 179, 4808–4820 (2007). doi: 10.4049/jimmunol.179.7.4808; pmid: 17878380
10. A. Moscona, Neuraminidase inhibitors for influenza. N. Engl. J. Med. 353, 1363–1373 (2005). doi: 10.1056/NEJMra050740; pmid: 16192481
11. K. Hata et al., Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob. Agents Chemother. 52, 3484–3491 (2008). doi: 10.1128/AAC.00344-08; pmid: 18694948
12. N. M. Stamatos et al., LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity. J. Leukoc. Biol. 88, 1227–1239 (2010). doi: 10.1189/ jlb.1209776; pmid: 20826611
13. B. Khor, A. Gardet, R. J. Xavier, Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011). doi: 10.1038/nature10209; pmid: 21677747
14. A. Kaser, S. Zeissig, R. S. Blumberg, Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573–621 (2010). doi: 10.1146/annurev-immunol-030409-101225; pmid: 20192811
15. P. J. Sansonetti, War and peace at mucosal surfaces. Nat. Rev. Immunol. 4, 953–964 (2004). doi: 10.1038/nri1499; pmid: 15573130
16. D. Knights, K. G. Lassen, R. J. Xavier, Advances in inflammatory bowel disease pathogenesis: Linking host genetics and the microbiome. Gut 62, 1505–1510 (2013). doi: 10.1136/ gutjnl-2012-303954; pmid: 24037875
17. J. Halfvarson, Genetics in twins with Crohn’s disease: Less pronounced than previously believed? Inflamm. Bowel Dis. 17, 6–12 (2011). doi: 10.1002/ibd.21295; pmid: 20848478
18. L. Eckmann, Animal models of inflammatory bowel disease: Lessons from enteric infections. Ann. N. Y. Acad. Sci. 1072, 28–38 (2006). doi: 10.1196/annals.1326.008; pmid: 17057188
19. A. Sonnenberg, Seasonal variation of enteric infections and inflammatory bowel disease. Inflamm. Bowel Dis. 14, 955–959 (2008). doi: 10.1002/ibd.20408; pmid: 18302273
20. Centers for Disease Control and Prevention (CDC), Vital signs: Incidence and trends of infection with pathogens transmitted commonly through food—Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 1996–2010. MMWR Morb. Mortal. Wkly. Rep. 60, 749–755 (2011). pmid: 21659984
21. E. Scallan et al., Foodborne illness acquired in the United States—Major pathogens. Emerg. Infect. Dis. 17, 7–15 (2011). doi: 10.3201/eid1701.P11101; pmid: 21192848
22. S. E. Majowicz et al.,The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 50, 882–889 (2010). doi: 10.1086/650733; pmid: 20158401
23. H. K. de Jong, C. M. Parry, T. van der Poll, W. J. Wiersinga, Host-pathogen interaction in invasive Salmonellosis. PLOS Pathog. 10, e1002933 (2012). doi: 10.1371/journal. ppat.1002933; pmid: 23055923
24. N. A. Feasey, G. Dougan, R. A. Kingsley, R. S. Heyderman, M. A. Gordon, Invasive non-typhoidal salmonella disease: An emerging and neglected tropical disease in Africa. Lancet 379, 2489–2499 (2012). doi: 10.1016/S0140-6736(11)61752-2; pmid: 22587967
25. B. F. Hinnebusch et al., Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Krüppel-like factor. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G23–G30 (2004). doi: 10.1152/ ajpgi.00203.2003; pmid: 12919939
26. K. Poelstra, W. W. Bakker, P. A. Klok, M. J. Hardonk, D. K. Meijer, A physiologic function for alkaline phosphatase: Endotoxin detoxification. Lab. Invest. 76, 319–327 (1997). pmid: 9121115
27. I. Koyama, T. Matsunaga, T. Harada, S. Hokari, T. Komoda, Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35, 455–461 (2002). doi: 10.1016/S0009-9120(02)00330-2; pmid: 12413606
28. J. M. Bates, J. Akerlund, E. Mittge, K. Guillemin, Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2, 371–382 (2007). doi: 10.1016/ j.chom.2007.10.010; pmid: 18078689
29. N. L. Sussman et al., Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes. Am. J. Physiol. 257, G14–G23 (1989). pmid: 2546440
30. L. G. Ellies et al., Sialyltransferase specificity in selectin ligand formation. Blood 100, 3618–3625 (2002). doi: 10.1182/blood-2002-04-1007; pmid: 12393657
31. W. H. Yang, C. Nussbaum, P. K. Grewal, J. D. Marth, M. Sperandio, Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands. Blood 120, 1015–1026 (2012). doi: 10.1182/blood-2012-04-424366; pmid: 22700726
32. N. Kamada, S. U. Seo, G. Y. Chen, G. Nunez, Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321–335 (2013). doi: 10.1038/nri3430; pmid: 23618829
33. N. A. Nagalingam, S. V. Lynch, Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 18, 968–984 (2012). doi: 10.1002/ibd.21866; pmid: 21936031
34. Y.-L. Huang, C. Chassard, M. Hausmann, M. von Itzstein, T. Hennet, Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nat. Commun. 6, 8141 (2015). doi: 10.1038/ncomms9141; pmid: 26303108
35. S. Ramasamy et al., Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm. Bowel Dis. 17, 532–542 (2011). doi: 10.1002/ibd.21377; pmid: 20645323
36. T. Dolowschiak et al., IFN-g hinders recovery from mucosal inflammation during antibiotic therapy for Salmonella gut infection. Cell Host Microbe 20, 238–249 (2016). doi: 10.1016/ j.chom.2016.06.008; pmid: 27453483
37. S. L. Foster, R. Medzhitov, Gene-specific control of the TLR-induced inflammatory response. Clin. Immunol. 130, 7–15 (2009). doi: 10.1016/j.clim.2008.08.015; pmid: 18964303
38. K. Kamdar et al., Genetic and metabolic signals during acute enteric bacterial infection alter the microbiota and drive progression to chronic inflammatory disease. Cell Host Microbe 19, 21–31 (2016). doi: 10.1016/j.chom.2015.12.006; pmid: 26764594
39. S. Manco et al., Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect. Immun. 74, 4014–4020 (2006). doi: 10.1128/IAI.01237-05; pmid: 16790774
40. S. M. Schwerdtfeger, M. F. Melzig, Sialidases in biological systems. Pharmazie 65, 551–561 (2010). pmid: 20824954
41. A. Varki, P. Gagneux, Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253, 16–36 (2012). doi: 10.1111/j.1749-6632.2012.06517.x; pmid: 22524423
42. K. Yamaguchi et al., Regulation of plasma-membrane-associated sialidase NEU3 gene by Sp1/Sp3 transcription factors. Biochem. J. 430, 107–117 (2010). doi: 10.1042/ BJ20100350; pmid: 20518744
43. W. Ma et al., The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276, 13664–13674 (2001). doi: 10.1074/jbc.M011157200; pmid: 11278848
44. V. S. Carl, J. K. Gautam, L. D. Comeau, M. F. Smith Jr., Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression. J. Leukoc. Biol. 76, 735–742 (2004). doi: 10.1189/jlb.1003526; pmid: 15218058
45. Y. Kakugawa et al., Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc. Natl. Acad. Sci. U.S.A. 99, 10718–10723 (2002). doi: 10.1073/pnas.152597199; pmid: 12149448
46. S. Kawamura et al., Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling. Cell Death Differ. 19, 170–179 (2012). doi: 10.1038/cdd.2011.83; pmid: 21681193
47. K. Yamaguchi et al., Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase. PLOS ONE 7, e41132 (2012). doi: 10.1371/journal.pone.0041132; pmid: 22815940
48. T. Wada et al., Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem. Biophys. Res. Commun. 261, 21–27 (1999). doi: 1006/bbrc.1999.0973; pmid: 10405317
49. A. Mozzi et al., NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels. Glycobiology 25, 855–868 (2015). doi: 10.1093/glycob/ cwv026; pmid: 25922362
50. K. Ohtsubo et al., Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123, 1307–1321 (2005). doi: 10.1016/j.cell.2005.09.041; pmid: 16377570
51. B. Weinhold et al., Genetic ablation of polysialic acid causes severe neurodevelopmental defects rescued by deletion of the neural cell adhesion molecule. J. Biol. Chem. 280, 42971–42977 (2005). doi: 10.1074/jbc.M511097200; pmid: 16267048
52. P. K. Grewal et al., ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol. Cell. Biol. 26, 4970–4981 (2006). doi: 10.1128/MCB.00308-06; pmid: 16782884
53. K. Ohtsubo, J. D. Marth, Glycosylation in cellular mechanisms of health and disease. Cell 126, 855–867 (2006). doi: 10.1016/ j.cell.2006.08.019; pmid: 16959566
54. P. R. Crocker, J. C. Paulson, A. Varki, Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255–266 (2007). doi: 10.1038/nri2056; pmid: 17380156
55. F.-T. Liu, G. A. Rabinovich, Galectins: Regulators of acute and chronic inflammation. Ann. N. Y. Acad. Sci. 1183, 158–182 (2010). doi: 10.1111/j.1749-6632.2009.05131.x; pmid: 20146714
56. A. Tuin et al., Role of alkaline phosphatase in colitis in man and rats. Gut 58, 379–387 (2009). doi: 10.1136/gut.2007.128868; pmid: 18852260
57. M. Lukas et al., Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm. Bowel Dis. 16, 1180–1186 (2010). doi: 10.1002/ ibd.21161; pmid: 19885903
58. K. Molnár et al., Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease. World J. Gastroenterol. 18, 3254–3259 (2012). doi: 10.3748/wjg.v18. i25.3254; pmid: 22783049
59. S. N. Alam et al., Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens. Ann. Surg. 259, 715–722 (2014). doi: 10.1097/ SLA.0b013e31828fae14; pmid: 23598380
60. J. J. Miklavcic et al., Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. World J. Gastroenterol. 21, 10080–10090 (2015). doi: 10.3748/wjg.v21.i35.10080; pmid: 26401073
61. R. F. Goldberg et al., Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc. Natl. Acad. Sci. U.S.A.. 105, 3551–3556 (2008). doi: 10.1073/ pnas.0712140105; pmid: 18292227
62. D. M. Heithoff et al., Intraspecies variation in the emergence of hyperinfectious bacterial strains in nature. PLOS Pathog. 8, e1002647 (2012). doi: 10.1371/journal.ppat.1002647; pmid: 22511871
63. J. Fu et al., Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J. Clin. Invest. 121, 1657–1666 (2011). doi: 10.1172/JCI45538; pmid: 21383503
64. S. Narisawa et al., Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol. Cell. Biol. 23, 7525–7530 (2003). doi: 10.1128/MCB.23.21.7525-7530.2003; pmid: 14560000
65. K. Ohtsubo, M. Z. Chen, J. M. Olefsky, J. D. Marth, Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat. Med. 17, 1067–1075 (2011). doi: 10.1038/nm.2414; pmid: 21841783
66. L. G. Ellies et al., Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc. Natl. Acad. Sci. U.S.A. 99, 10042–10047 (2002). doi: 10.1073/pnas.142005099; pmid: 12097641
67. M. R. Davis Jr., J. B. Goldberg, Purification and visualization of lipopolysaccharide from Gram-negative bacteria by hot aqueous-phenol extraction. J. Vis. Exp. 2012, 3916 (2012). doi: 10.3791/3916; pmid: 22688346
68. C.-H. Lee, C.-M. Tsai, Quantification of bacterial lipopolysaccharides by the purpald assay: Measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal. Biochem. 267, 161–168 (1999). doi: 10.1006/abio.1998.2961; pmid: 9918668
69. N. J. Foot et al., Ndfip1–deficient mice have impaired DMT1 regulation and iron homeostasis. Blood 117, 638–646 (2011). doi: 10.1182/blood-2010-07-295287; pmid: 20959604.
70. A. Fuhrer et al., Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J. Exp. Med. 207, 2843–2854 (2010). doi: 10.1084/jem.20101098; pmid: 21098096
71. M. H. Zaki et al., The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379–391 (2010). doi: 10.1016/ j.immuni.2010.03.003; pmid: 20303296